Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
HCC
.
Show all posts
Showing posts with label
HCC
.
Show all posts
Saturday, July 14, 2012
Tivantinib Meets Study Endpoint
›
ArQule Inc . and Daiichi Sankyo Co. Ltd. announced that a Phase 2 trial data using tivantinib as a single agent investigational second-...
›
Home
View web version
